BlueCrest Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,000
| Closed | -$1.39M | – | 76 |
|
|
2024
Q4 | $1.39M | Sell |
6,000
-3,000
| -33% | -$690K | 0.04% | 70 |
|
|
2024
Q3 | $1.99M | Buy |
+9,000
| New | +$1.86M | 0.11% | 52 |
|
|
2021
Q4 | – | Sell |
-28,750
| Closed | -$5.56M | – | 314 |
|
|
2021
Q3 | $5.56M | Hold |
28,750
| – | – | 0.15% | 125 |
|
|
2021
Q2 | $6.12M | Hold |
28,750
| – | – | 0.11% | 178 |
|
|
2021
Q1 | $5.87M | Hold |
28,750
| – | – | 0.1% | 260 |
|
|
2020
Q4 | $5.23M | Hold |
28,750
| – | – | 0.12% | 183 |
|
|
2020
Q3 | $4.81M | Hold |
28,750
| – | – | 0.18% | 122 |
|
|
2020
Q2 | $4.67M | Hold |
28,750
| – | – | 0.25% | 87 |
|
|
2020
Q1 | $4.97M | Sell |
28,750
-16,250
| -36% | -$3.23M | 0.34% | 55 |
|
|
2019
Q4 | $9.03M | Sell |
45,000
-480
| -1% | -$98.5K | 0.58% | 37 |
|
|
2019
Q3 | $9.61M | Buy |
45,480
+467
| +1% | +$97.6K | 0.66% | 35 |
|
|
2019
Q2 | $8.74M | Sell |
45,013
-5
| -0% | -$922 | 0.62% | 36 |
|
|
2019
Q1 | $7.41M | Sell |
45,018
-191
| -0.4% | -$33.8K | 0.3% | 46 |
|
|
2018
Q4 | $8.51M | Sell |
45,209
-1,479
| -3% | -$273K | 0.44% | 44 |
|
|
2018
Q3 | $7.95M | Buy |
46,688
+1,688
| +4% | +$284K | 0.21% | 68 |
|
|
2018
Q2 | $7.38M | Sell |
45,000
-208,242
| -82% | -$34M | 0.19% | 110 |
|
|
2018
Q1 | $41M | Buy |
253,242
+207,869
| +458% | +$33.1M | 1.28% | 5 |
|
|
2017
Q4 | $6.63M | Buy |
45,373
+266
| +0.6% | +$37.9K | 0.18% | 113 |
|
|
2017
Q3 | $6.12M | Sell |
45,107
-53,843
| -54% | -$6.8M | 0.25% | 103 |
|
|
2017
Q2 | $12.4M | Sell |
98,950
-34,391
| -26% | -$4.11M | 0.48% | 39 |
|
|
2017
Q1 | $15.8M | Sell |
133,341
-5,252
| -4% | -$632K | 0.75% | 24 |
|
|
2016
Q4 | $16M | Buy |
138,593
+88,601
| +177% | +$9.86M | 0.88% | 9 |
|
|
2016
Q3 | $5.22M | Sell |
49,992
-60,637
| -55% | -$6.33M | 0.17% | 141 |
|
|
2016
Q2 | $10.8M | Buy |
110,629
+65,487
| +145% | +$6.19M | 0.45% | 30 |
|
|
2016
Q1 | $4.34M | Sell |
45,142
-1,227
| -3% | -$112K | 0.27% | 103 |
|
|
2015
Q4 | $4.2M | Sell |
46,369
-10,607
| -19% | -$998K | 0.17% | 134 |
|
|
2015
Q3 | $5.28M | Sell |
56,976
-80,248
| -58% | -$7.63M | 0.17% | 107 |
|
|
2015
Q2 | $12.8M | Buy |
137,224
+92,224
| +205% | +$8.6M | 0.37% | 38 |
|
|
2015
Q1 | $4.26M | Sell |
45,000
-60,609
| -57% | -$5.61M | 0.23% | 131 |
|
|
2014
Q4 | $9.36M | Buy |
105,609
+60,609
| +135% | +$5.14M | 0.3% | 53 |
|
|
2014
Q3 | $3.6M | Buy |
+45,000
| New | +$3.39M | 0.14% | 145 |
|
Other funds holding CME
TIM
BlueCrest Capital Management's CME Position: Q1 2025 in Review
BlueCrest Capital Management sold out of CME Group (CME) in Q1 2025, closing a stake of 6,000 shares — an estimated $1.39M sold.
BlueCrest Capital Management first reported a position in CME in Q3 2014 and held it in 31 quarters. The position peaked at $41M in Q1 2018. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.
- BlueCrest Capital Management reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
- BlueCrest Capital Management sold 6,000 CME Group shares in Q1 2025, an estimated $1.39M.
- BlueCrest Capital Management first reported a position in CME Group in Q3 2014 and held it in 31 quarters.
- BlueCrest Capital Management's CME Group position peaked at $41M in Q1 2018.
- 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.
Based on BlueCrest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.